Cargando…
Prevalence of hepatopancreatic injury and clinical outcomes in patients with COVID-19 in USA
BACKGROUND: (1) To determine the prevalence of hepatopancreatic injury in coronavirus disease 2019 (COVID-19) patients. (2) To correlate hepatopancreatic injury in COVID-19 with mortality, disease severity, and length of stay in this cohort. RESULTS: Forty-five thousand three hundred sixty patients...
Autores principales: | Rastogi, Vaibhav, Banwait, Ranjit, Singh, Devina, Toklu, Hale, Finer, Lexie, Parajuli, Dipendra, Ganti, Latha |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8572059/ https://www.ncbi.nlm.nih.gov/pubmed/34742236 http://dx.doi.org/10.1186/s12245-021-00393-2 |
Ejemplares similares
-
Renin-Angiotensin-Aldosterone System Blockers Prior to Hospitalization and Their Association With Clinical Outcomes in Coronavirus Disease 2019 (COVID-19)
por: Banwait, Ranjit, et al.
Publicado: (2021) -
Can Neuron Specific Enolase Be a Diagnostic Biomarker for Neuronal Injury in COVID-19?
por: Ganti, Latha, et al.
Publicado: (2020) -
Cerebrospinal fluid findings and hypernatremia in COVID-19 patients with altered mental status
por: Toklu, Hale, et al.
Publicado: (2020) -
Awareness of the CDC “Heads Up!” to Youth Sports Campaign among Pediatric Sports Coaches: A Pilot Survey
Study
por: Stead, Thor S, et al.
Publicado: (2016) -
Spontaneous Mediastinal Emphysema
por: Singh, Devina, et al.
Publicado: (2018)